Stock BHSC BIOHARVEST SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News BioHarvest Sciences Inc.

Equities

BHSC

CA09076J1084

Market Closed - Canadian Securities Exchange
Other stock markets
 02:00:13 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.26 CAD +1.96% Intraday chart for BioHarvest Sciences Inc. 0.00% +20.93%
Apr. 16 BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity CI
Feb. 26 BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility
AQ
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
CI
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
NE
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit
AQ
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
NE
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
NE
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
NE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
NE
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
NE
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules
MT
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit
CI
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit
CI
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
NE
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm
NE
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
NE
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
NE
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
NE
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement
NE
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding
CI
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BHSC Stock
  4. News BioHarvest Sciences Inc.